Palantir: Doctors urge major health think tank to cut ties with controversial technology company Post date 30 September 2025 ← What does Trump’s H-1B visa ban mean for doctors in the US? → Lecanamab: Controversial Alzheimer’s drug approved by Australian drugs regulator after two rejections